Additionally, M3H67 immunoreactivity, as a marker for MAGE-A expression, mainly MAGE-A3, was found to be associated with poor prognosis in gastrointestinal stromal tumors [38]. Here, MAGEA3 is linked to gastrointestinal stromal tumor.